Letters Pioglitazone use and risk of bladder cancer Authors’ reply to Gallagher and Winocour BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i3668 (Published 06 July 2016) Cite this as: BMJ 2016;354:i3668 Article Related content Metrics Responses Peer review Related articles Research Pioglitazone use and risk of bladder cancer: population based cohort study Published: 30 March 2016; BMJ 352 doi:10.1136/bmj.i1541 See more Breast cancer: Inaction on inequalities has led to unequal progress, say experts BMJ April 16, 2024, 385 q854; DOI: https://doi.org/10.1136/bmj.q854 Cancer: Fast tracked drugs often do not improve clinical outcomes, say researchers BMJ April 08, 2024, 385 q818; DOI: https://doi.org/10.1136/bmj.q818 NHS rolls out fast tracked immunotherapy for advanced endometrial cancer BMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557 Teledentistry may help in detecting oral cancers in current GP and dentist shortages BMJ March 01, 2024, 384 q512; DOI: https://doi.org/10.1136/bmj.q512 UK’s progress on cancer survival has slowed in past decade, figures show BMJ February 02, 2024, 384 q290; DOI: https://doi.org/10.1136/bmj.q290
